Papers

2

Total Citations

30

H-Index

2

About

No biography available yet.

Research Focus

Key Achievements

2
H-Index
2
Papers
30
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study
28 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 48
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Not generated yet